Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1995 Feb;162(2):158–160.

Impotence related to anabolic steroid use in a body builder. Response to clomiphene citrate.

C Bickelman 1, L Ferries 1, R P Eaton 1
PMCID: PMC1022657  PMID: 7725695

Full text

PDF
158

Images in this article

159Image
on p.159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adashi E. Y. Clomiphene citrate: mechanism(s) and site(s) of action--a hypothesis revisited. Fertil Steril. 1984 Sep;42(3):331–344. doi: 10.1016/s0015-0282(16)48069-6. [DOI] [PubMed] [Google Scholar]
  2. Brower K. J., Eliopulos G. A., Blow F. C., Catlin D. H., Beresford T. P. Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psychiatry. 1990 Apr;147(4):510–512. doi: 10.1176/ajp.147.4.510. [DOI] [PubMed] [Google Scholar]
  3. Caminos-Torres R., Ma L., Snyder P. J. Testosterone-induced inhibition of the LH and FSH responses to gonadotropin-releasing hormone occurs slowly. J Clin Endocrinol Metab. 1977 Jun;44(6):1142–1153. doi: 10.1210/jcem-44-6-1142. [DOI] [PubMed] [Google Scholar]
  4. Jarow J. P., Lipshultz L. I. Anabolic steroid-induced hypogonadotropic hypogonadism. Am J Sports Med. 1990 Jul-Aug;18(4):429–431. doi: 10.1177/036354659001800417. [DOI] [PubMed] [Google Scholar]
  5. Kashkin K. B., Kleber H. D. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA. 1989 Dec 8;262(22):3166–3170. doi: 10.1001/jama.262.22.3166. [DOI] [PubMed] [Google Scholar]
  6. Kennedy M. C. Anabolic steroid abuse and toxicology. Aust N Z J Med. 1992 Aug;22(4):374–381. doi: 10.1111/j.1445-5994.1992.tb02151.x. [DOI] [PubMed] [Google Scholar]
  7. Martin-Malo A., Benito P., Castillo D., Espinosa M., Burdiel L. G., Perez R., Aljama P. Effect of clomiphene citrate on hormonal profile in male hemodialysis and kidney transplant patients. Nephron. 1993;63(4):390–394. doi: 10.1159/000187240. [DOI] [PubMed] [Google Scholar]
  8. Mauss J., Börsch G., Bormacher K., Richter E., Leyendecker G., Nocke W. Effect of long-term testosterone oenanthate administration on male reproductive function: clinical evaluation, serum FSH, LH, testosterone, and seminal fluid analyses in normal men. Acta Endocrinol (Copenh) 1975 Feb;78(2):373–384. doi: 10.1530/acta.0.0780373. [DOI] [PubMed] [Google Scholar]
  9. Perry P. J., Andersen K. H., Yates W. R. Illicit anabolic steroid use in athletes. A case series analysis. Am J Sports Med. 1990 Jul-Aug;18(4):422–428. doi: 10.1177/036354659001800416. [DOI] [PubMed] [Google Scholar]
  10. Smith D. A., Perry P. J. The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids. Ann Pharmacother. 1992 Apr;26(4):520–528. doi: 10.1177/106002809202600414. [DOI] [PubMed] [Google Scholar]
  11. Uzych L. Anabolic-androgenic steroids and psychiatric-related effects: a review. Can J Psychiatry. 1992 Feb;37(1):23–28. doi: 10.1177/070674379203700106. [DOI] [PubMed] [Google Scholar]
  12. Yesalis C. E., Kennedy N. J., Kopstein A. N., Bahrke M. S. Anabolic-androgenic steroid use in the United States. JAMA. 1993 Sep 8;270(10):1217–1221. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES